ResearcherNational Institutes of HealthNo recent work listed

Nan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1498-7139; OpenAlex author ID A5100341038. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. Co-author DOI 10.1038/s41467-023-37616-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Stephen M. Hewitt · 1 shared paper, 2023 · strength 0.16
- Paper The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC… DOI 10.1038/s41467-023-37616-4 ↗
Mitchell Ho · 1 shared paper, 2023 · strength 0.16
- Paper The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC… DOI 10.1038/s41467-023-37616-4 ↗
Hua Ren · 1 shared paper, 2023 · strength 0.16
- Paper The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC… DOI 10.1038/s41467-023-37616-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.